CONDUIT PHARMACEUTICALS INC (CDT) Stock Price, Quote, News and Overview
NASDAQ:CDT - Nasdaq - US20678X2053 - Common Stock - Currency: USD
CDT Quote, Performance and Key Statistics
0.5024
-0.03 (-6.39%)
The current stock price of CDT is 0.5024 USD. In the past month the price decreased by -22.19%. In the past year, price decreased by -99.83%.
CDT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.28 | 159.40B | ||
| DHR | DANAHER CORP | 26.5 | 141.27B | ||
| A | AGILENT TECHNOLOGIES INC | 20.41 | 30.90B | ||
| IQV | IQVIA HOLDINGS INC | 13.67 | 26.85B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.97 | 22.74B | ||
| WAT | WATERS CORP | 29.35 | 20.73B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.77 | 15.16B | ||
| ILMN | ILLUMINA INC | 31.91 | 12.37B | ||
| ICLR | ICON PLC | 10.42 | 11.81B | ||
| RVTY | REVVITY INC | 18.83 | 11.15B | ||
| TEM | TEMPUS AI INC | N/A | 9.36B | ||
| QGEN | QIAGEN N.V. | 19.37 | 9.25B |
Related stock screener links
About CDT
Company Profile
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in Naples Florida, Florida and currently employs 6 full-time employees. The company went IPO on 2022-02-03. The firm is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company’s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection and Hashimoto’s Thyroiditis. The Company’s asset pipeline includes AZD1656 (a Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. The company is used as a treatment option for Hashimoto’s Thyroiditis (HT and Graves’ disease, including investigating any negative side effects of the use of AZD1656 as compared with treatment options for Hashimoto’s Thyroiditis and Graves’ disease. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), that has the potential to treat Idiopathic Male Infertility (IMI).
Company Info
CONDUIT PHARMACEUTICALS INC
4851 Tamiami Trail North, Suite 200
Naples Florida FLORIDA US
Employees: 7
Phone: 16464919132
CONDUIT PHARMACEUTICALS INC / CDT FAQ
What is the stock price of CONDUIT PHARMACEUTICALS INC today?
The current stock price of CDT is 0.5024 USD. The price decreased by -6.39% in the last trading session.
What is the ticker symbol for CONDUIT PHARMACEUTICALS INC stock?
The exchange symbol of CONDUIT PHARMACEUTICALS INC is CDT and it is listed on the Nasdaq exchange.
On which exchange is CDT stock listed?
CDT stock is listed on the Nasdaq exchange.
What is CONDUIT PHARMACEUTICALS INC worth?
CONDUIT PHARMACEUTICALS INC (CDT) has a market capitalization of 5.70M USD. This makes CDT a Nano Cap stock.
How many employees does CONDUIT PHARMACEUTICALS INC have?
CONDUIT PHARMACEUTICALS INC (CDT) currently has 7 employees.
Should I buy CONDUIT PHARMACEUTICALS INC (CDT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CDT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CDT, evaluating the profitability, health, valuation and growth aspects
- CONDUIT PHARMACEUTICALS INC (CDT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CONDUIT PHARMACEUTICALS INC (CDT) Sales and EPS estimates to see what analysts future expectations are.
- CONDUIT PHARMACEUTICALS INC (CDT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CONDUIT PHARMACEUTICALS INC (CDT) Insider and Institutional Ownership to learn about the owners and their transactions.
- CONDUIT PHARMACEUTICALS INC (CDT) Stock Chart to make your own analysis
- CONDUIT PHARMACEUTICALS INC (CDT) Latest news and press-releases to stay up to date.
Does CONDUIT PHARMACEUTICALS INC (CDT) stock pay dividends?
CDT does not pay a dividend.
What is the Price/Earnings (PE) ratio of CONDUIT PHARMACEUTICALS INC (CDT)?
CONDUIT PHARMACEUTICALS INC (CDT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.34).
What is the Short Interest ratio of CONDUIT PHARMACEUTICALS INC (CDT) stock?
The outstanding short interest for CONDUIT PHARMACEUTICALS INC (CDT) is 18.02% of its float. Check the ownership tab for more information on the CDT short interest.
CDT Technical Analysis
CDT Financial Highlights
Over the last trailing twelve months CDT reported a non-GAAP Earnings per Share(EPS) of -2.34. The EPS decreased by -11600% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -424.56% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |